Antibodies

Israeli startup to use AI to transform antibody discovery, design

"The launch of CombinAble heralds a shift in the approach to targeted antibody design by leveraging AI to optimize and expedite the discovery process," said Mati Gill, CEO of AION Labs.

 AI (Artificial Intelligence) letters and robot hand miniature in this illustration taken, June 23, 2023.
 (l-r) Ariel Tennenhouse, Lev Khmelnitsky, Prof. Sarel Fleishman, Razi Khalaila

Researchers find new way to make animal antibodies safe for humans

 A highly contagious viral disease. Influenza virus

Flu viruses may be combated with new antibody, study finds

ADULTS SHOULD aim for seven to nine hours, and older adults should aim for seven to eight hours.

Sleeping less than six hours will decrease vaccine effectiveness - study


Children infected by COVID continue to have antibodies - How protected are they?

Study shows that children infected with COVID-19 continue to have antibodies at least six months afterwards, but protection against Omicron still unclear.

 Coronavirus cells (illustrative)

COVID-19: How many antibodies are enough? - opinion

Evusheld is a new medication from AstraZeneca designed specifically for people who are immunocompromised.

 TESTING CHILDREN aged 3 to 12 for antibodies, in Katrin, Aug. 2021.

Antibody quality improves for months after COVID-19 vaccination- study

Even low levels of antibodies would continue to provide some protection against disease, the researchers said — as long as the virus doesn’t change.

 A Palestinian student receives a dose of the COVID-19 vaccine, in Dura, in the West Bank city of Hebron, January 24, 2022.

COVID-19: Highly concentrated antibody solution not effective treatment - study

The trial, backed by Dr. Anthony Fauci's NIAID, tested the combination of anti-coronavirus hyperimmune intravenous immunoglobulin and remdesivir.

 COVID-19 (illustrative)

High number of Omicron mutations render antibodies ineffective - study

New research indicates the 46 mutations found in the COVID-19 Omicron variant have rendered antibodies ineffective, accounting for the high number of re-infections and breakthrough cases.

 Coronavirus cells (illustrative)

Vaccinated women can pass COVID-19 antibodies to their babies - study

It should be noted that mRNA coronavirus vaccines are safe for pregnant women and no risk factors have been found as a result of vaccination while pregnant.

 Pregnant woman (illustrative)

Even asymptomatic COVID-19 could lead to long-term damage - study

New research from Cedars-Sinai is the first to report not only the presence of elevated autoantibodies after mild or asymptomatic infection, but their persistence over time.

People queue at Westminster Bridge to receive COVID-19 vaccine and booster doses, as the spread of the coronavirus disease (COVID-19) continues, at a walk-in vaccination centre at Saint Thomas' Hospital in London, Britain, December 14, 2021.

Israeli antibody treatment co. acquires four FDA-approved drugs

The combined 2021 annual global revenue from the four products is expected to be around $45 million. 

Kamada's factory in Beit Kama

COVID-19: Israel starts accepting antigen tests to enter the country

Beginning Friday, travelers will be able to undergo a rapid test 24 hours before takeoff instead of a more cumbersome PCR test.

 Magen David worker take a COVID-19 rapid antigen test from Israelis, at a Magen David Adom testing center in Jerusalem, on September 26, 2021.

Malaysia treatment of Israel is backward - editorial

Malaysia is refusing to give visas to an Israeli squad hoping to participate in next month’s World Team Squash Championship in Kuala Lumpur.

 Malasian flag.